Maximilian Filzmayer

Frankfurt Am Main, HE 60596, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

ASO Visual Abstract: Risk-adapted use of adjuvant systemic therapy after nephrectomy for renal cell carcinoma: a population-based study in the post-approval era.

ASO Visual Abstract: Risk-adapted use of adjuvant systemic therapy after nephrectomy for renal cell carcinoma: a population-based study in the post-approval era.

Journal: Annals of surgical oncology

Published: August 10, 2026

ASO Author Reflections: Risk-Adapted Use of Adjuvant Systemic Therapy in Real-World Kidney Cancer Care.

ASO Author Reflections: Risk-Adapted Use of Adjuvant Systemic Therapy in Real-World Kidney Cancer Care.

Journal: Annals of surgical oncology

Published: July 30, 2026

Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era.

Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era.

Journal: Annals of surgical oncology

Published: May 28, 2026

Temporal trends and sociodemographic determinants of time to nephrectomy in localized renal cell cancer.

Temporal trends and sociodemographic determinants of time to nephrectomy in localized renal cell cancer.

Journal: International urology and nephrology

Published: May 20, 2026

Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after Nephroureterectomy.

Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after Nephroureterectomy.

Journal: Urologia internationalis

Published: May 11, 2026

Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United States.

Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United States.

Journal: The Prostate

Published: April 28, 2026

Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinoma.

Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinoma.

Journal: World journal of surgical oncology

Published: March 24, 2026

ASO Visual Abstract: Alcohol Use Disorder Versus Adverse In-hospital Outcomes After Radical Cystectomy and Ileal Conduit Urinary Diversion.

ASO Visual Abstract: Alcohol Use Disorder Versus Adverse In-hospital Outcomes After Radical Cystectomy and Ileal Conduit Urinary Diversion.

Journal: Annals of surgical oncology

Published: March 24, 2026

Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with focal therapy vs. radical prostatectomy.

Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with focal therapy vs. radical prostatectomy.

Journal: Urologic oncology

Published: March 17, 2026

ASO Visual Abstract: Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy.

ASO Visual Abstract: Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy.

Journal: Annals of surgical oncology

Published: March 16, 2026

Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study.

Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 06, 2026

Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate.

Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate.

Journal: Lower urinary tract symptoms

Published: March 02, 2026

Showing 1-12 of 36

Last Updated: 09/26/2026